0

Companion Animal Healthcare Market by Product and Geography - Forecast and Analysis 2022-2026

  • Published: Jul 2022
  • Pages: 127
  • SKU: IRTNTR74077
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

The companion animal healthcare market share is expected to increase by USD 9.82 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 9.25%.

This companion animal healthcare market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers companion animal healthcare market segmentation by product (pharmaceuticals and diagnostics) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The companion animal healthcare market report also offers information on several market vendors, including Agrolabo Spa, Bayer AG, C. H. Boehringer Sohn AG, and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Eco Animal Health Group Plc, Elanco Animal Health Inc., Endovac Animal Health, Heska Corp., IDEXX Laboratories Inc., Indian Immunologicals Ltd., Innovate, Kyoritsuseiyaku Corp., LABORATORIOS HIPRA SA, Merck and Co. Inc., Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, and Zoetis Inc. among others.

What will the Companion Animal Healthcare Market Size be During the Forecast Period?

Companion Animal Healthcare Market Size

Download Report Sample to Unlock the Companion Animal Healthcare Market Size for the Forecast Period and Other Important Statistics

 

Companion Animal Healthcare Market: Key Drivers, Trends, and Challenges

The rising pet ownership is notably driving the companion animal healthcare market growth, although factors such as stringent regulatory approval processes for drugs may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the companion animal healthcare industry. The holistic analysis of the drivers will help deduce end goals and refine marketing strategies to gain a competitive edge.

Key Companion Animal Healthcare Market Driver

Rising pet ownership is one of the major drivers impacting the companion animal healthcare market growth. Growing pet ownership and humanization of pets are complementing the growth of the global companion animal healthcare market during the forecast period. Most pet owners believe that pets have a positive impact on their lives. Around 90% of dog owners, specifically, believe that their dogs make a huge contribution to their physical and mental health. According to the American Pet Products Association (APPA) 2020-2021 APPA National Pet Owners Survey, over 67% of American households, which equates to 84.9 million homes, own at least one pet in their house. Therefore, the increasing adoption of pets in households is driving the demand for animal healthcare units for check-ups on pet's health conditions, propelling the growth of the global companion animal healthcare market during the forecast period.

Key Companion Animal Healthcare Market Trend

Rising awareness about pet insurance is one of the major trends influencing the companion animal healthcare market growth. Pet insurance can help support unexpected costs incurred by pet owners while providing the best veterinary care for pets. The marginal adoption of pet insurance is due to the rigid pet insurance policies, most of which cover only accidental injuries. Countries such as the US and Canada are looking for new insurance policies for pets, which can help them cover the medical expenses of their pets. The demand for pet insurance has increased in parts of APAC. The rise in demand for pet insurance is due to the increased availability of animal medical treatment and surgeries, improvement in technologies related to treatment, and the increasing age of pets leading to several health problems. The diagnostics and treatments for pet health problems are expensive, which increases the demand for pet insurance. Therefore, the growing popularity of pet insurance should help owners avail of proper medical treatment, thereby driving the growth of the global companion animal healthcare market during the forecast period.

Key Companion Animal Healthcare Market Challenge

Stringent regulatory approval processes for drugs are one of the major challenges impeding the companion animal healthcare market growth. The US FDA, the Canadian Food Agency, the European Medicines Agency, the Ministry of Agriculture, Forestry, and Fisheries (MAFF), and the Australian Pesticides and Veterinary Medicines Authority (APVMA) is among the major regulatory bodies that approve veterinary medicines. The Veterinary International Committee for Harmonization (VICH) also plays a vital role in bringing regulatory agencies from the US, Europe, and Japan together; it also harmonizes guidelines and technical standards for veterinary product registration. These regulatory authorities have established severe guidelines for the approval of veterinary pharmaceutical drugs. In nations such as Australia, Japan, and China, regulatory criteria for the authorization of novel veterinary pharmaceutical products, such as antimicrobials, antibiotics, vaccines, parasiticides, and other pharmaceutical products, are also highly stringent. All these factors are reducing the growth of the focused market during the forecast period.

This companion animal healthcare market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global companion animal healthcare market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the companion animal healthcare market during the forecast period.

Who are the Major Companion Animal Healthcare Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Agrolabo Spa
  • Bayer AG
  • C. H. Boehringer Sohn AG and Co. KG
  • Ceva Sante Animale
  • Chanelle Pharma Group
  • Dechra Pharmaceuticals Plc
  • Eco Animal Health Group Plc
  • Elanco Animal Health Inc.
  • Endovac Animal Health
  • Heska Corp.
  • IDEXX Laboratories Inc.
  • Indian Immunologicals Ltd.
  • Inovet
  • Kyoritsuseiyaku Corp.
  • LABORATORIOS HIPRA SA
  • Merck and Co. Inc.
  • Norbrook Laboratories Ltd.
  • Vetoquinol SA
  • Virbac Group
  • Zoetis Inc.

 

This statistical study of the companion animal healthcare market encompasses successful business strategies deployed by the key vendors. The companion animal healthcare market is fragmented and the vendors are deploying growth strategies such as M&A, distribution through partnerships, participation in medical trade shows, and product development through the use of advanced technologies to compete in the market.

Product Insights and News

  • virbac.com - The company offers companion animal health products such as parasiticides, immunology, and antibiotics products.
  • virbac.com - The company offers parasiticides, immunology products, antibiotics for dermatology, equine, and specialized pet food products.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The companion animal healthcare market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Companion Animal Healthcare Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the companion animal healthcare market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the pharmaceuticals market includes the following core components:

  • Inputs
  • Inbound logistics
  • Operations
  • Outbound logistics
  • Marketing and sales
  • Service
  • Support activities
  • Innovation

The report has further elucidated other innovative approaches being followed by service providers to ensure a sustainable market presence.

 

Which are the Key Regions for Companion Animal Healthcare Market?

Companion Animal Healthcare Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

43% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for companion animal healthcare market in North America. Market growth in this region will be faster than the growth of the market in other regions.

The growing interest in pet ownership in countries such as the US and Canada will facilitate the companion animal healthcare market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 negatively impacted the market in this region. Due to the adverse effects of COVID-19, a large number of animal healthcare facilities were forced to lay off employees. Therefore, the growth of the companion animal healthcare market in North America declined in the first half of 2020. However, in the second half of 2020, several veterinary healthcare service providers started offering animal healthcare services through digital channels, which enabled the market to deal with the pandemic's negative effects by registering growth through the online channel. Furthermore, in 2021, as a result of large-scale vaccination campaigns and there was the restoration of operations in animal healthcare units, as compared to 2020, due to the suspension of lockdown restrictions, which allowed the market in focus to develop significantly in North America. This growth is expected to continue during the forecast period.

What are the Revenue-generating Product Segments in the Companion Animal Healthcare Market?

Companion Animal Healthcare Market Share

To gain further insights on the market contribution of various segments Request a PDF Sample

The companion animal healthcare market share growth in the pharmaceuticals segment will be significant during the forecast period. In 2021, pharmaceuticals were the largest and fastest-growing application segment of the companion animal healthcare market. The rise in pet ownership, rising zoonotic disease incidence, rising demand for pet insurance in association with rising animal healthcare expenses, and activities by several government agencies and animal associations are the main factors driving this market's growth. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the companion animal healthcare market size and actionable market insights on post COVID-19 impact on each segment.

 

Companion Animal Healthcare Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 9.25%

Market growth 2022-2026

$ 9.82 billion

Market structure

Fragmented

YoY growth (%)

8.65

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 43%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Agrolabo Spa, Bayer AG, C. H. Boehringer Sohn AG, and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Eco Animal Health Group Plc, Elanco Animal Health Inc., Endovac Animal Health, Heska Corp., IDEXX Laboratories Inc., Indian Immunologicals Ltd., Inovet, Kyoritsuseiyaku Corp., LABORATORIOS HIPRA SA, Merck and Co. Inc., Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, and Zoetis Inc. 

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Companion Animal Healthcare Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive companion animal healthcare market growth during the next five years
  • Precise estimation of the companion animal healthcare market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the companion animal healthcare industry across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of companion animal healthcare market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Product

    • 5.1 Market segments
      • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
    • 5.2 Comparison by Product
      • Exhibit 26: Chart on Comparison by Product
      • Exhibit 27: Data Table on Comparison by Product
    • 5.3 Pharmaceuticals - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Pharmaceuticals - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Pharmaceuticals - Year-over-year growth 2021-2026 (%)
    • 5.4 Diagnostics - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Diagnostics - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Diagnostics - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Diagnostics - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Diagnostics - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by Product
      • Exhibit 36: Market opportunity by Product ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 40: Chart on Geographic comparison
      • Exhibit 41: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 UK - Market size and forecast 2021-2026
      • Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.10 Canada - Market size and forecast 2021-2026
      • Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.11 China - Market size and forecast 2021-2026
      • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 78: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 81: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 82: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 83: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 84: Matrix on vendor position and classification
            • 10.3 Bayer AG
              • Exhibit 85: Bayer AG - Overview
              • Exhibit 86: Bayer AG - Business segments
              • Exhibit 87: Bayer AG - Key offerings
              • Exhibit 88: Bayer AG - Segment focus
            • 10.4 C. H. Boehringer Sohn AG and Co. KG
              • Exhibit 89: C. H. Boehringer Sohn AG and Co. KG - Overview
              • Exhibit 90: C. H. Boehringer Sohn AG and Co. KG - Business segments
              • Exhibit 91: C. H. Boehringer Sohn AG and Co. KG - Key news
              • Exhibit 92: C. H. Boehringer Sohn AG and Co. KG - Key offerings
              • Exhibit 93: C. H. Boehringer Sohn AG and Co. KG - Segment focus
            • 10.5 Ceva Sante Animale
              • Exhibit 94: Ceva Sante Animale - Overview
              • Exhibit 95: Ceva Sante Animale - Product / Service
              • Exhibit 96: Ceva Sante Animale - Key offerings
            • 10.6 Dechra Pharmaceuticals Plc
              • Exhibit 97: Dechra Pharmaceuticals Plc - Overview
              • Exhibit 98: Dechra Pharmaceuticals Plc - Business segments
              • Exhibit 99: Dechra Pharmaceuticals Plc - Key offerings
              • Exhibit 100: Dechra Pharmaceuticals Plc - Segment focus
            • 10.7 Heska Corp.
              • Exhibit 101: Heska Corp. - Overview
              • Exhibit 102: Heska Corp. - Business segments
              • Exhibit 103: Heska Corp. - Key news
              • Exhibit 104: Heska Corp. - Key offerings
              • Exhibit 105: Heska Corp. - Segment focus
            • 10.8 IDEXX Laboratories Inc.
              • Exhibit 106: IDEXX Laboratories Inc. - Overview
              • Exhibit 107: IDEXX Laboratories Inc. - Business segments
              • Exhibit 108: IDEXX Laboratories Inc. - Key news
              • Exhibit 109: IDEXX Laboratories Inc. - Key offerings
              • Exhibit 110: IDEXX Laboratories Inc. - Segment focus
            • 10.9 Indian Immunologicals Ltd.
              • Exhibit 111: Indian Immunologicals Ltd. - Overview
              • Exhibit 112: Indian Immunologicals Ltd. - Product / Service
              • Exhibit 113: Indian Immunologicals Ltd. - Key offerings
            • 10.10 Merck and Co. Inc.
              • Exhibit 114: Merck and Co. Inc. - Overview
              • Exhibit 115: Merck and Co. Inc. - Business segments
              • Exhibit 116: Merck and Co. Inc. - Key news
              • Exhibit 117: Merck and Co. Inc. - Key offerings
              • Exhibit 118: Merck and Co. Inc. - Segment focus
            • 10.11 Virbac Group
              • Exhibit 119: Virbac Group - Overview
              • Exhibit 120: Virbac Group - Business segments
              • Exhibit 121: Virbac Group - Key news
              • Exhibit 122: Virbac Group - Key offerings
              • Exhibit 123: Virbac Group - Segment focus
            • 10.12 Zoetis Inc.
              • Exhibit 124: Zoetis Inc. - Overview
              • Exhibit 125: Zoetis Inc. - Business segments
              • Exhibit 126: Zoetis Inc. - Key news
              • Exhibit 127: Zoetis Inc. - Key offerings
              • Exhibit 128: Zoetis Inc. - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 129: Inclusions checklist
                • Exhibit 130: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 131: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 132: Research methodology
                • Exhibit 133: Validation techniques employed for market sizing
                • Exhibit 134: Information sources
              • 11.5 List of abbreviations
                • Exhibit 135: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Companion Animal Healthcare market growth will increase by $9822.8 million during 2022-2026.
              The companion animal healthcare market is expected to grow at a CAGR of 9.25% during 2022-2026.
              Technavio has segmented the companion animal healthcare market by geographic (North America, Europe, Asia, and Rest of World (ROW)).
              Agrolabo Spa, Bayer AG, C. H. Boehringer Sohn AG and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Eco Animal Health Group Plc, Elanco Animal Health Inc., Endovac Animal Health, Heska Corp., IDEXX Laboratories Inc., Indian Immunologicals Ltd., Inovet, Kyoritsuseiyaku Corp., LABORATORIOS HIPRA SA, Merck and Co. Inc., Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, Zoetis Inc. are a few of the key vendors in the companion animal healthcare market.
              North America will register the highest growth rate of 43.2% among the other regions. Therefore, the companion animal healthcare market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the companion animal healthcare market growth are:
              • Rising pet ownership
              • Rising awareness about pet insurance
              The companion animal healthcare market vendors should focus on grabbing business opportunities from the segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single User:

                Quick and easy buy and download option

              • Enterprise:

                Flexible option - Complimentary customization included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>